We Look at Eucrisa® for Eczema
Eucrisa™ (crisaborole) is a topical ointment for adults and children 3 months and older used to treat eczema (atopic dermatitis). It is a non-steroidal topical...
Learn more about the effectiveness and side effects of today’s prescription drugs for common skin conditions, and possible alternatives.
CASE STUDY: Eczema and a Switch from Dupixent®
Eczema can be stubborn to treat if you’re not addressing the root cause. Here’s a case study of one of our eczema patients who tried...
We Look at Ebglyss® for Eczema
In September of 2024, the FDA approved Ebglyss™ (lebrikizumab-lbkz manufactured by Eli Lily and Company) as a prescription treatment for moderate to severe eczema (atopic...
We Look at Zoryve® for Eczema and Psoriasis
In July of 2024, the FDA approved Zoryve® cream (roflumilast) for the treatment of mild to moderate eczema in adults and children ages 6 and...
We Look at Tremfya® for Psoriasis
Tremfya® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis, and/or psoriatic arthritis. It contains the active drug guselkumab and...
Psoriasis? We Look at Taltz®
Taltz® (Ixekizumab) is an injectable medicine used to treat those 6 years of age and older with moderate to severe plaque psoriasis. It is a...
We Take A Look at Opzelura (TM)
OpzeluraTM is a relatively new medication, receiving FDA approval in 2021 as the first topical treatment of its kind for atopic dermatitis (eczema). It is...
We Look at New Psoriasis Medication – SOTYKTU®
The FDA approved the new prescription treatment for Psoriasis, Sotyktu®, in September of 2022. Produced by Bristol Meyers Squibb, Sotyktu® is an oral medication, taken...
FAQ: Switching from Skyrizi® to Herbal Medicine
A new prescription medication Skyrizi® was approved for patients with plaque psoriasis in April 2019. However, some patients may experience negative side effects. Others may...
- 1
- 2